[go: up one dir, main page]

FI20000073A0 - Uusia imidatsolijohdannaisia - Google Patents

Uusia imidatsolijohdannaisia

Info

Publication number
FI20000073A0
FI20000073A0 FI20000073A FI20000073A FI20000073A0 FI 20000073 A0 FI20000073 A0 FI 20000073A0 FI 20000073 A FI20000073 A FI 20000073A FI 20000073 A FI20000073 A FI 20000073A FI 20000073 A0 FI20000073 A0 FI 20000073A0
Authority
FI
Finland
Prior art keywords
imidazole derivatives
new imidazole
formula
new
derivative
Prior art date
Application number
FI20000073A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Paavo Huhtala
Arto Karjalainen
Antti Haapalinna
Jyrki Lehtimaeki
Arja Karjalainen
Raimo Virtanen
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Priority to FI20000073A priority Critical patent/FI20000073A0/fi
Publication of FI20000073A0 publication Critical patent/FI20000073A0/fi
Priority to GCP20011133 priority patent/GC0000218A/en
Priority to PT01942360T priority patent/PT1261588E/pt
Priority to DE60106572T priority patent/DE60106572T2/de
Priority to AT01942360T priority patent/ATE280161T1/de
Priority to ARP010100140A priority patent/AR029432A1/es
Priority to ES01942360T priority patent/ES2228884T3/es
Priority to KR1020027009037A priority patent/KR20020084091A/ko
Priority to SK998-2002A priority patent/SK286320B6/sk
Priority to NZ519919A priority patent/NZ519919A/en
Priority to BR0107644-2A priority patent/BR0107644A/pt
Priority to HU0301008A priority patent/HUP0301008A3/hu
Priority to EEP200200389A priority patent/EE200200389A/xx
Priority to MXPA02006872A priority patent/MXPA02006872A/es
Priority to PCT/FI2001/000030 priority patent/WO2001051472A1/en
Priority to RU2002121777/04A priority patent/RU2265598C2/ru
Priority to DK01942360T priority patent/DK1261588T3/da
Priority to EP01942360A priority patent/EP1261588B1/en
Priority to PE2001000029A priority patent/PE20011230A1/es
Priority to AU28532/01A priority patent/AU769896B2/en
Priority to CNB018037194A priority patent/CN1187336C/zh
Priority to JP2001551854A priority patent/JP2003519688A/ja
Priority to IL15050601A priority patent/IL150506A0/xx
Priority to PL356884A priority patent/PL207281B1/pl
Priority to CA002397283A priority patent/CA2397283A1/en
Priority to HK03102023.4A priority patent/HK1049999B/zh
Priority to CZ20022358A priority patent/CZ20022358A3/cs
Priority to SI200130256T priority patent/SI1261588T1/xx
Priority to ZA200205301A priority patent/ZA200205301B/xx
Priority to NO20023298A priority patent/NO323117B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI20000073A 2000-01-14 2000-01-14 Uusia imidatsolijohdannaisia FI20000073A0 (fi)

Priority Applications (30)

Application Number Priority Date Filing Date Title
FI20000073A FI20000073A0 (fi) 2000-01-14 2000-01-14 Uusia imidatsolijohdannaisia
GCP20011133 GC0000218A (en) 2000-01-14 2001-01-10 New imidazole derivatives
SI200130256T SI1261588T1 (en) 2000-01-14 2001-01-12 IMIDAZOLE COMPOUNDS AS Alpha2-ADRENOCEPTORS ANTAGONISTS
PCT/FI2001/000030 WO2001051472A1 (en) 2000-01-14 2001-01-12 New imidazole derivatives
RU2002121777/04A RU2265598C2 (ru) 2000-01-14 2001-01-12 Производные имидазола, способ их получения, фармацевтические композиции на их основе и способ лечения с их использованием
AT01942360T ATE280161T1 (de) 2000-01-14 2001-01-12 Imidazolverbindungen als alpha2-adrenorezeptoren antagonisten
ARP010100140A AR029432A1 (es) 2000-01-14 2001-01-12 Derivados de imidazol 1-sustituido que poseen afinidad con los alfa2-adrenorreceptores, uso de dichos derivados como medicamentos y/o para la preparacion de composiciones farmaceuticas formuladas con dichos compuestos de 1-imidazol sustituido, proceso para preparar dichos derivados
ES01942360T ES2228884T3 (es) 2000-01-14 2001-01-12 Nuevos derivados de imidazol.
KR1020027009037A KR20020084091A (ko) 2000-01-14 2001-01-12 신규 이미다졸 유도체
SK998-2002A SK286320B6 (en) 2000-01-14 2001-01-12 Imidazole derivative, method for its preparing and use and pharmaceutical compositions containing it
NZ519919A NZ519919A (en) 2000-01-14 2001-01-12 Imidazole substituted by an indene, indane or benzofuran derivative useful as alpha2 receptor agonist
BR0107644-2A BR0107644A (pt) 2000-01-14 2001-01-12 Derivados de imidazol
HU0301008A HUP0301008A3 (en) 2000-01-14 2001-01-12 New imidazole derivatives, process for their preparation, their use and pharmaceutical compositions containing them
EEP200200389A EE200200389A (et) 2000-01-14 2001-01-12 Imidasooli uued derivaadid
MXPA02006872A MXPA02006872A (es) 2000-01-14 2001-01-12 Nuevos derivados de imidazol.
PT01942360T PT1261588E (pt) 2000-01-14 2001-01-12 Compostos imidazole como antagonistas dos adrenoceptores
DE60106572T DE60106572T2 (de) 2000-01-14 2001-01-12 IMIDAZOLVERBINDUNGEN ALS Alpha2-ADRENOREZEPTOREN ANTAGONISTEN
DK01942360T DK1261588T3 (da) 2000-01-14 2001-01-12 Imidazolforbindelser som alfa2-adrenoceptorantagonister
EP01942360A EP1261588B1 (en) 2000-01-14 2001-01-12 IMIDAZOLE COMPOUNDS AS Alpha2-ADRENOCEPTORS ANTAGONISTS
PE2001000029A PE20011230A1 (es) 2000-01-14 2001-01-12 Derivados de imidazol como agonistas de alfa- 2- adrenoreceptores
AU28532/01A AU769896B2 (en) 2000-01-14 2001-01-12 New imidazole derivatives
CNB018037194A CN1187336C (zh) 2000-01-14 2001-01-12 咪唑类衍生物
JP2001551854A JP2003519688A (ja) 2000-01-14 2001-01-12 イミダゾール誘導体
IL15050601A IL150506A0 (en) 2000-01-14 2001-01-12 New imidazole derivatives
PL356884A PL207281B1 (pl) 2000-01-14 2001-01-12 Pochodna imidazolu, kompozycja ją zawierająca, jej zastosowanie i sposób wytwarzania
CA002397283A CA2397283A1 (en) 2000-01-14 2001-01-12 New imidazole derivatives
HK03102023.4A HK1049999B (zh) 2000-01-14 2001-01-12 咪唑類衍生物
CZ20022358A CZ20022358A3 (cs) 2000-01-14 2001-01-12 Nové deriváty imidazolu
ZA200205301A ZA200205301B (en) 2000-01-14 2002-07-02 New imidazole derivatives.
NO20023298A NO323117B1 (no) 2000-01-14 2002-07-08 Nye imidazolderivater

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20000073A FI20000073A0 (fi) 2000-01-14 2000-01-14 Uusia imidatsolijohdannaisia

Publications (1)

Publication Number Publication Date
FI20000073A0 true FI20000073A0 (fi) 2000-01-14

Family

ID=8557065

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20000073A FI20000073A0 (fi) 2000-01-14 2000-01-14 Uusia imidatsolijohdannaisia

Country Status (30)

Country Link
EP (1) EP1261588B1 (da)
JP (1) JP2003519688A (da)
KR (1) KR20020084091A (da)
CN (1) CN1187336C (da)
AR (1) AR029432A1 (da)
AT (1) ATE280161T1 (da)
AU (1) AU769896B2 (da)
BR (1) BR0107644A (da)
CA (1) CA2397283A1 (da)
CZ (1) CZ20022358A3 (da)
DE (1) DE60106572T2 (da)
DK (1) DK1261588T3 (da)
EE (1) EE200200389A (da)
ES (1) ES2228884T3 (da)
FI (1) FI20000073A0 (da)
GC (1) GC0000218A (da)
HK (1) HK1049999B (da)
HU (1) HUP0301008A3 (da)
IL (1) IL150506A0 (da)
MX (1) MXPA02006872A (da)
NO (1) NO323117B1 (da)
NZ (1) NZ519919A (da)
PE (1) PE20011230A1 (da)
PL (1) PL207281B1 (da)
PT (1) PT1261588E (da)
RU (1) RU2265598C2 (da)
SI (1) SI1261588T1 (da)
SK (1) SK286320B6 (da)
WO (1) WO2001051472A1 (da)
ZA (1) ZA200205301B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20002756A0 (fi) * 2000-12-15 2000-12-15 Orion Yhtymae Oyj Uusi hoitomenetelmä
TW200306783A (en) 2002-04-29 2003-12-01 Fmc Corp Pesticidal heterocycles
FI20022159A0 (fi) 2002-12-05 2002-12-05 Orion Corp Uusia farmaseuttisia yhdisteitä
DE102004035322A1 (de) * 2004-07-21 2006-02-16 Universität des Saarlandes Selektive Hemmstoffe humaner Corticoidsynthasen
CN101528710B (zh) 2006-10-19 2012-11-07 弗·哈夫曼-拉罗切有限公司 氨基甲基-4-咪唑类
EP2084152A2 (en) * 2006-11-16 2009-08-05 F. Hoffmann-Roche AG Substituted 4-imidazoles
US20080146523A1 (en) 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
AR090557A1 (es) * 2012-04-02 2014-11-19 Orion Corp DERIVADOS IMIDAZOLICOS AGONISTAS ADRENERGICOS a2

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2225782A (en) * 1988-12-09 1990-06-13 Farmos Group Limited Imidazole derivatives useful for treatment of diabetes
GB2244431A (en) * 1990-05-31 1991-12-04 Farmos Oy Treatment of age related memory impairment and other cognitive disorders
US5541211A (en) * 1991-06-18 1996-07-30 Orion-Yhtyma Oy Administration of atipamezole to elicit a yohimbine-like alpha-adrenoreceptor antagonistic noradrenergic transmission
GB9113077D0 (en) * 1991-06-18 1991-08-07 Orion Yhtymae Oy Use of atipamezole
GB9127050D0 (en) * 1991-12-20 1992-02-19 Orion Yhtymae Oy Substituted imidazole derivatives and their preparation and use
GB9520150D0 (en) * 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
BR9813381A (pt) * 1997-12-04 2000-10-03 Allergan Sales Inc "derivados de imidazol substituìdo possuindo atividade semelhante a agonista em receptores adrenérgicos alfa 2b ou 2b/2c"
US6503935B1 (en) * 1998-08-07 2003-01-07 Abbott Laboratories Imidazoles and related compounds as α1A agonists
TWI283669B (en) * 1999-06-10 2007-07-11 Allergan Inc Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors

Also Published As

Publication number Publication date
JP2003519688A (ja) 2003-06-24
HK1049999B (zh) 2005-05-13
ES2228884T3 (es) 2005-04-16
DK1261588T3 (da) 2005-02-14
HUP0301008A2 (hu) 2003-10-28
DE60106572D1 (de) 2004-11-25
ATE280161T1 (de) 2004-11-15
EP1261588A1 (en) 2002-12-04
IL150506A0 (en) 2003-02-12
CZ20022358A3 (cs) 2007-12-19
SK9982002A3 (en) 2003-03-04
PE20011230A1 (es) 2001-12-08
CN1395567A (zh) 2003-02-05
WO2001051472A1 (en) 2001-07-19
SK286320B6 (en) 2008-07-07
RU2265598C2 (ru) 2005-12-10
SI1261588T1 (en) 2005-02-28
EP1261588B1 (en) 2004-10-20
GC0000218A (en) 2006-03-29
WO2001051472A9 (en) 2003-01-23
ZA200205301B (en) 2003-10-02
AR029432A1 (es) 2003-06-25
DE60106572T2 (de) 2006-02-09
MXPA02006872A (es) 2003-01-28
AU769896B2 (en) 2004-02-05
NZ519919A (en) 2003-10-31
BR0107644A (pt) 2002-10-08
NO20023298L (no) 2002-09-06
PL207281B1 (pl) 2010-11-30
CA2397283A1 (en) 2001-07-19
EE200200389A (et) 2003-10-15
HK1049999A1 (en) 2003-06-06
PL356884A1 (en) 2004-07-12
HUP0301008A3 (en) 2004-01-28
NO323117B1 (no) 2007-01-08
PT1261588E (pt) 2005-02-28
CN1187336C (zh) 2005-02-02
RU2002121777A (ru) 2004-01-10
KR20020084091A (ko) 2002-11-04
NO20023298D0 (no) 2002-07-08
AU2853201A (en) 2001-07-24

Similar Documents

Publication Publication Date Title
NO20060219L (no) Forbindelser
ATE353216T1 (de) 1-substituierten imidazol derivaten als nos inhibitoren
IL161074A0 (en) Lactam derivatives as antagonists for human 11cby receptors
DE60210944D1 (de) N-substituierte heterocyclische nichtaryl-nmda/nr2b-antagonisten
DE60107449D1 (de) Substituierte aminopropoxyarylderivate als lxr agonisten
CY1112991T1 (el) ΠΑΡΑΓΩΓΑ ΙΝΔΟΛΗΣ Ή ΒΕΝΖΙΜΙΔΑΖΟΛΗΣ ΓΙΑ ΤΗ ΡΥΘΜΙΣΗ ΤΗΣ ΙκΒ ΚΙΝΑΣΗΣ ΚΑΙ ΕΝΔΙΑΜΕΣΑ ΠΡΟΪΟΝΤΑ ΓΙΑ ΤΗΝ ΠΑΡΑΣΚΕΥΗ ΤΟΥΣ
IL148932A0 (en) INHIBITORS OF αLβ2 MEDIATED CELL ADHESION
DE60328035D1 (de) Neue azolderivate
YU173791A (sh) Indol i benzimidazol-supstituisani imidazol i benzimidazol derivati
TR200403436T2 (tr) Kristalin 1-metilkarbapenem türevleri.
FI20000073A0 (fi) Uusia imidatsolijohdannaisia
NO20022232D0 (no) Imidazolforbindelser for anvendelse som inhibitorer for fosfodiesterase VII
SE0103710D0 (sv) Compounds
MXPA04004802A (es) Derivados del 1,2,4-triazol que contienen un grupo sulfamato como inhibidores de aromatasa.
BR0209050A (pt) Azóis de ação inseticida
DK1222193T3 (da) Imidazolderivater som phosphodiesterase VII-inhibitorer
EA200300238A1 (ru) Триазольные производные и фармацевтические композиции, содержащие их
DK193090A (da) Imidazolyl- og pyridylderivater af phenylsubstituerede 1,4-dihydropyridiner og fremgangsmaade til fremstilling deraf
FR2801055B1 (fr) Derives de beta-d-5-thioxylose, procede de preparation et utilisation en therapeutique
HRP20050617A2 (en) Imidazol derivatives having affinity for alpha 2 receptors activity
DE60211018D1 (de) Fungizide thiazolderivate
DK1296965T3 (da) Fremgangsmåde til fremstilling af 4-brom-anilinderivater
DK0705266T3 (da) Fremgangsmåde til fremstilling af et imidazolderivat.